Showing 1 - 4 results of 4 for search 'J. J. Zwaginga', query time: 0.02s Refine Results
  1. 1
    P1630: WEARABLES IN TRANSFUSION MEDICINE: CHALLENGES AND FUTURE PERSPECTIVE

    P1630: WEARABLES IN TRANSFUSION MEDICINE: CHALLENGES AND FUTURE PERSPECTIVE by R. Tonino, M. Schipperus, J. J. Zwaginga

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Hemoglobin modulation affects physiology and patient reported outcomes in anemic and non-anemic subjects: An umbrella review

    Hemoglobin modulation affects physiology and patient reported outcomes in anemic and non-anemic subjects: An umbrella review by R. P. B. Tonino, R. P. B. Tonino, R. P. B. Tonino, L. M. Zwaginga, M. R. Schipperus, M. R. Schipperus, M. R. Schipperus, J. J. Zwaginga, J. J. Zwaginga

    Published 2023-02-01
    Get full text
    Article
  3. 3
    P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).

    P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY). by A. G. Jansen, V. McDonald, A. Newland, M. Morgan, S. Visser-Peereboom, K. Wilson, D. Eriksson, E. Geldman, O. Daykin-Pont, J. J. Zwaginga

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL

    P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL by L. Oosten, M. van Pel, B. van der Holt, E. Bach, M. Cross, H. Roelofs, P. Meij, B. Wieles, J. J. Zwaginga, A. Lankester, H. Veelken, U. Platzbecker, F. Sanchez-Guijo, M. Algeri, F. Locatelli, T. Devos, J. Cornelissen, D. Niederwieser, W. Fibbe

    Published 2022-06-01
    Get full text
    Article

Search Tools: